← Leaderboards
Debra Burnin
Sri International
$9,670,591
Attributed
$9,670,591
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.4M · FY2022–25$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$9,670,591 · 2
By mechanism
N01$9,670,591 · 2
Top collaborators
No co-investigators on record.
Most similar at Sri International
Same institution · by research overlap
- Toufan Parman$25,866,968
- Deborah Bunin$11,920,896
- Leyi Gong$9,484,648
- Kathryn Baughman$29,412,662
- Carol E Green$19,982,282
Others in their field
Other Rising Stars on “National Institute Of Child Health And Human Development”
- Cathryn Peltz · Henry Ford Health + Michigan State University Health Sciences$7,977,678
- Michele Caggana · Nysdoh/Health Research, Inc.$3,494,712
- Allison Leigh Speer · University Of Texas Hlth Sci Ctr Houston$3,234,095
- John Parkinson · Thetis Pharmaceuticals, Llc$2,996,955
- Sarah N Cilvik · Wake Forest University Health Sciences$2,943,331
- Christine K. Fox · University Of California, San Francisco$2,672,011
Research focus
National Institute Of Child Health And Human DevelopmentIn VivoEvaluationAnimalsIn VitroDrug FormulationsContraceptive AgentsDesignFormulationBiological TestingToxic EffectOvulationLot ProductionPre-ClinicalContraceptive MethodsProduct DevelopmentClinical LotResearch Clinical TestingPharmacokinetics And PharmacodynamicsPlasmaPharmacologic SubstanceResearch SupportPlayPharmaceutical Preparations
Grant awards (12)
NONCLINICAL DEVELOPMENT OF CONTRACEPTIVE PRODUCTS FOR MEN AND/OR WOMEN$684,493
N01 · FY2025 · HD · contact PI
BIOLOGICAL TESTING FACILITY-REGULATORY, DATA ANALYSIS, DATABASE, AND PROJECT MANAGEMENT$149,973
N01 · FY2025 · HD · contact PI
BIOLOGICAL TESTING FACILITY (BTF) â GOOD LABORATORY PRACTICE (GLP) TOXICOLOGY AND FERTILITY AND EARLY EMBRYONIC DEVELOPMENT (FEED) STUDIES AND PRECLINICAL STUDIES OF CONTRACEPTIVES$2,369,376
N01 · FY2024 · HD · contact PI
BIOLOGICAL TESTING FACILITY (BTF) - PRECLINICAL DEVELOPMENT OF CONTRACEPTIVE PRODUCTS$1,017,684
N01 · FY2024 · HD · contact PI
PK/PD, METABOLIC, AND PRECLINICAL STUDIES - SRI INTERNATIONAL$2,084,983
N01 · FY2023 · HD · contact PI
BIOLOGICAL TESTING FACILITY (BTF) - FORMULATION AND PHARMACEUTICAL CHARACTERIZATION OF MULTIPURPOSE PREVENTION CONTRACEPTION PREVENTION$49,975
N01 · FY2023 · HD · contact PI
BIOLOGICAL TESTING FACILITY - DMAU$3,556
N01 · FY2023 · HD · contact PI
BIOLOGICAL TESTING FACILITY - STABILITY TESTING, CLINICAL FORMULATION DEVELOPMENT AND MANUFACTURING ACTIVITIES OF CONTRACEPTIVE AGENTS$1,199,506
N01 · FY2022 · HD · contact PI
BIOLOGICAL TESTING FACILITY (BTF) - NONCLINICAL FEMALE CONTRACEPTIVE DEVELOPMENT SERVICES$1,099,997
N01 · FY2022 · HD · contact PI
BIOLOGICAL TESTING FACILITY â IN VITRO METABOLIC AND IN VIVO PRECLINICAL STUDIES$604,936
N01 · FY2022 · HD · contact PI
BIOLOGICAL TESTING FACILITY (BTF) - NONCLINICAL MALE CONTRACEPTIVE DEVELOPMENT SERVICES$352,571
N01 · FY2022 · HD · contact PI
BIOLOGICAL TESTING FACILITY (BTF): TASK ORDER 12- "FORMULATION AND PHARMACEUTICAL CHARACTERIZATION OF MULTIPURPOSE PREVENTION CONTRACEPTION PREVENTION$53,541
N01 · FY2022 · HD · contact PI